Whether clinical staging is more suitable for the affect of surgical complications on survival after neoadjuvant therapy?

Eur J Surg Oncol. 2024 Jun;50(6):108296. doi: 10.1016/j.ejso.2024.108296. Epub 2024 Mar 26.

Authors

Kexun Li¹, Xiaobo Chen¹, Jiapeng Yang²

Affiliations

¹ Department of Thoracic Surgery I, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, China.
² Department of Thoracic Surgery I, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, China. Electronic address: docyangjiapeng@163.com.

PMID: 38555231
DOI: 10.1016/j.ejso.2024.108296

No abstract available

Publication types

Editorial
Letter

MeSH terms

Humans
Neoadjuvant Therapy*
Neoplasm Staging*
Postoperative Complications*
Survival Rate